159 related articles for article (PubMed ID: 30411196)
1. New Classes of Polycationic Compounds as Preservatives for Ophthalmic Formulations.
von Deylen D; Dreher C; Seidelmann O; Reichl S
Pharm Res; 2018 Nov; 36(1):11. PubMed ID: 30411196
[TBL] [Abstract][Full Text] [Related]
2. Influence of different additives and their concentrations on corneal toxicity and antimicrobial effect of benzalkonium chloride.
Onizuka N; Uematsu M; Kusano M; Sasaki H; Suzuma K; Kitaoka T
Cornea; 2014 May; 33(5):521-6. PubMed ID: 24619166
[TBL] [Abstract][Full Text] [Related]
3. Effects of the Ophthalmic Additive Mannitol on Antimicrobial Activity and Corneal Toxicity of Various Preservatives.
Inaba K; Minami M; Yamaguchi M; Goto R; Otake H; Kotake T; Nagai N
Chem Pharm Bull (Tokyo); 2020; 68(11):1069-1073. PubMed ID: 33132373
[TBL] [Abstract][Full Text] [Related]
4. Ophthalmic preservatives: focus on polyquaternium-1.
Rolando M; Crider JY; Kahook MY
Expert Opin Drug Deliv; 2011 Nov; 8(11):1425-38. PubMed ID: 21905766
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Structure and Antimicrobial Properties of Novel Benzalkonium Chloride Analogues with Pyridine Rings.
Brycki B; Małecka I; Koziróg A; Otlewska A
Molecules; 2017 Jan; 22(1):. PubMed ID: 28098790
[TBL] [Abstract][Full Text] [Related]
6. In vitro effects of preserved and unpreserved anti-allergic drugs on human corneal epithelial cells.
Guzman-Aranguez A; Calvo P; Ropero I; Pintor J
J Ocul Pharmacol Ther; 2014 Nov; 30(9):790-8. PubMed ID: 25100331
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of a new preservative for multiuse ophthalmic solutions.
Ghelardi E; Celandroni F; Gueye SA; Salvetti S; Campa M; Senesi S
J Ocul Pharmacol Ther; 2013; 29(6):586-90. PubMed ID: 23428175
[TBL] [Abstract][Full Text] [Related]
8. Effects of Benzalkonium Chloride and Preservative-Free Composition on the Corneal Epithelium Cells.
Kabashima K; Murakami A; Ebihara N
J Ocul Pharmacol Ther; 2020 Nov; 36(9):672-678. PubMed ID: 32552267
[No Abstract] [Full Text] [Related]
9. Optimising concentrations of antimicrobial agents in pharmaceutical preparations: Case of an oral solution of glycerol and an ophthalmic solution containing cysteamine.
Chan Hew Wai A; Becasse P; Tworski S; Pradeau D; Planas V
Ann Pharm Fr; 2014 Nov; 72(6):415-21. PubMed ID: 25438652
[TBL] [Abstract][Full Text] [Related]
10. Acute cytotoxic effects of marketed ophthalmic formulations on human corneal epithelial cells.
Hakkarainen JJ; Reinisalo M; Ragauskas S; Seppänen A; Kaja S; Kalesnykas G
Int J Pharm; 2016 Sep; 511(1):73-78. PubMed ID: 27374205
[TBL] [Abstract][Full Text] [Related]
11. Comparison of fluoroquinolones: cytotoxicity on human corneal epithelial cells.
Tsai TH; Chen WL; Hu FR
Eye (Lond); 2010 May; 24(5):909-17. PubMed ID: 19648900
[TBL] [Abstract][Full Text] [Related]
12. In vitro effects of benzalkonium chloride and prostaglandins on human meibomian gland epithelial cells.
Rath A; Eichhorn M; Träger K; Paulsen F; Hampel U
Ann Anat; 2019 Mar; 222():129-138. PubMed ID: 30580056
[TBL] [Abstract][Full Text] [Related]
13. Biological Synergy and Antimicrobial Mechanism of Hydroxypropyltrimethyl Ammonium Chloride Chitosan with Benzalkonium Chloride.
Qian Y; Zhang L; Gu X; Wei L; Wang J; Wang Y
Chem Pharm Bull (Tokyo); 2021; 69(7):612-619. PubMed ID: 34193710
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis.
Engel LS; Callegan MC; Hill JM; Folkens AT; Shimomura Y; O'Callaghan RJ
Jpn J Ophthalmol; 1996; 40(2):212-9. PubMed ID: 8876389
[TBL] [Abstract][Full Text] [Related]
15. Seven-day viable analysis of some ophthalmic preparations with different concentrations of benzalkonium chloride.
Adil H; Sheikh D; Ahmed I; Sheikh MR; Ali G
Pak J Pharm Sci; 1995 Jul; 8(2):1-10. PubMed ID: 16420997
[TBL] [Abstract][Full Text] [Related]
16. Decrease in Corneal Damage due to Benzalkonium Chloride by the Addition of Mannitol into Timolol Maleate Eye Drops.
Nagai N; Yoshioka C; Tanino T; Ito Y; Okamoto N; Shimomura Y
J Oleo Sci; 2015; 64(7):743-50. PubMed ID: 26136174
[TBL] [Abstract][Full Text] [Related]
17. Polyquaternium-1-Preserved Travoprost 0.003% or Benzalkonium Chloride-Preserved Travoprost 0.004% for Glaucoma and Ocular Hypertension.
Peace JH; Ahlberg P; Wagner M; Lim JM; Wirta D; Branch JD
Am J Ophthalmol; 2015 Aug; 160(2):266-274.e1. PubMed ID: 25935098
[TBL] [Abstract][Full Text] [Related]
18. The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo.
Pellinen P; Huhtala A; Tolonen A; Lokkila J; Mäenpää J; Uusitalo H
Curr Eye Res; 2012 Feb; 37(2):145-54. PubMed ID: 22049909
[TBL] [Abstract][Full Text] [Related]
19. Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1: an experimental study.
Labbé A; Pauly A; Liang H; Brignole-Baudouin F; Martin C; Warnet JM; Baudouin C
J Ocul Pharmacol Ther; 2006 Aug; 22(4):267-78. PubMed ID: 16910868
[TBL] [Abstract][Full Text] [Related]
20. In vitro comparative toxicology of polyquad-preserved and benzalkonium chloride-preserved travoprost/timolol fixed combination and latanoprost/timolol fixed combination.
Brignole-Baudouin F; Riancho L; Liang H; Nakib Z; Baudouin C
J Ocul Pharmacol Ther; 2011 Jun; 27(3):273-80. PubMed ID: 21410334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
